By: Aanu Adeoye, Oliver Barnes
Oliver Barnes is a US pharmaceutical and biotech correspondent at the Financial Times. He focuses on scientific innovation, blockbuster drugs, and access to healthcare, while also having a background in covering gambling, tobacco, and hospitality industries. Oliver's work has been featured in notable publications including The Irish Times, The Manila Times, and Yahoo Finance.
















